ChemPass AI

Unlocking success in small molecule-based
product development

ChemPass AI is an innovative, validated computational chemistry discovery and development tech-engine for designing novel small molecule-based products.

ChemPass AI integrates validated innovative chemo-informatics tools focused on various product-related attributes and development hurdles, and a robust, highly-efficient virtual screening platform. It utilizes a set of advanced AI chemo-informatics tools and a routinely updated database of curated and processed data on molecules available for purchase and synthesis. ChemPass AI drives and accelerates the small molecule product development process.

Explore ChemPass AI

Discovery

ChemPass AI uses a set of innovative tools to achieve optimal outcomes for small molecule targeted discovery. Its TargetSelecetor proprietary tool can highlight optimal protein targets based on a myriad of criteria. Utilizing Deep Learning computational technologies, ChemPass AI, can then screen and identify small molecule candidates from an extensive >35B molecule database in a short period while meeting multiple product attributes.

ChemPass AI integrates multiple product-related considerations for selecting small molecules that meet pre-defined criteria, such as novel mechanism of action, ADME-Tox, various properties, or others.

Development

Small molecule hits, leads, or commercial products are optimized and developed using a set of dedicated AI-based tools that automatically expand the hits’ chemical space, allowing researchers to cycle through a Structure Activity Relationship (SAR) process in a timely and cost-effective manner while maintaining all necessary attributes.

ChemPass AI combines large, well-organized, searchable databases and related innovative chemo-informatic tools to search, invent and analyze new small molecules before their expensive synthesis and testing.